Join a walk for Crohn's & Colitis.
Register for a walk near you!
Train for a half marathon while raising funds for crucial research. Teams
forming now -- find yours today!
Senate Resolution 199 supports first Crohn’s and Colitis Awareness Week
New York, NY -- The week of December 1-7 has been designated by the Crohn’s & Colitis Foundation of America (CCFA) as Crohn’s and Colitis Awareness Week in order to encourage all Americans to join in the effort to find cures for these diseases, help raise awareness and support research.
Senate Resolution 199 expresses appreciation to the family members and caregivers who support people in the United States living with Crohn’s disease and ulcerative colitis. It also commends health care professionals who care for these patients and biomedical researchers who work to advance research aimed at developing new treatments for Crohn’s disease and ulcerative colitis.
“The passage of this resolution will give hope to the millions of Americans, including a growing number of young children, who struggle with Crohn’s disease and ulcerative colitis that we will continue to focus our attention on these very difficult diseases,” said Senate Majority Leader Harry Reid (D-NV).
Known collectively as inflammatory bowel disease (IBD), Crohn’s disease and ulcerative colitis affects 1 in 200 people. They are painful, medically incurable diseases that attack the digestive system. Crohn's disease may attack anywhere along the digestive track, while ulcerative colitis inflames only the large intestine (colon). Symptoms may include abdominal pain, persistent diarrhea, rectal bleeding, fever and weight loss. Many patients require numerous hospitalizations and surgery.
“These are common disorders with bad consequences if not detected and treated early,” said Lloyd Mayer, MD, Chair of the Crohn’s & Colitis Foundation of America’s National Scientific Advisory Committee. “Yet long delays in diagnosis and effective treatment are common because people, including primary care physicians, are not familiar with the symptoms. The average delay in diagnosis is 1-3 years and the average patient is misdiagnosed twice.”
“We are grateful to the Senate for passing this resolution because we know increased awareness of IBD can accelerate proper diagnosis and treatment,” said Richard Geswell, President of the Crohn’s & Colitis Foundation of America. “Our researchers are working furiously to find cures, and in the meantime, CCFA is taking care of the people suffering from these diseases.”
The lead sponsors of the resolution were Senate Majority Leader Harry Reid (D-NV) and Senator Thad Cochran (R-MS). The other seven Senate co-sponsors were: Senators Jack Reed (D-RI), Kirsten Gillibrand (D-NY), Patty Murray (D-WA), Charles Schumer (D-NY), Maria Cantwell (D-WA), Richard Burr (R-NC) and Diane Feinstein (D-CA).
In support of Crohn’s and Colitis Awareness week, the Crohn’s & Colitis Foundation of America is asking people to:
- Write to their House Representatives and encourage them to join the Crohn’s and Colitis Caucus
- “Like” the Crohn’s & Colitis Foundation of America on Facebook (www.facebook.com/ccfafb) and follow the Foundation on Twitter (twitter.com/ccfa)
- Change your Facebook status to INSERT in support of Crohn’s and Colitis Awareness Week
- Reach out to anyone you know with IBD and let them know you care
- Visit www.crohnscolitisfoundation.org to learn more about the disease
Crohn's & Colitis Foundation
The Crohn's & Colitis Foundation of America's mission is to cure Crohn's disease and ulcerative colitis, and to improve the quality of life of children and adults affected by these diseases. The Foundation ranks third among leading health non-profits in the percentage of expense devoted to research toward a cure, with more than 80 cents of every dollar the Foundation spends going to mission-critical programs. The Foundation consistently meets the standards of organizations that monitor charities, including the Better Business Bureau's Wise Giving Alliance (give.org) and the American Institute of Philanthropy (charitywatch.org).